Skip to main content
Log in

Effects of pramipexole on the processing of rewarding and aversive taste stimuli

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Pramipexole, a D2/D3 dopamine receptor agonist, has been implicated in the development of impulse control disorders in patients with Parkinson's disease. Investigation of single doses of pramipexole in healthy participants in reward-based learning tasks has shown inhibition of the neural processing of reward, presumptively through stimulation of dopamine autoreceptors.

Objectives

This study aims to examine the effects of pramipexole on the neural response to the passive receipt of rewarding and aversive sight and taste stimuli.

Methods

We used functional magnetic resonance imaging to examine the neural responses to the sight and taste of pleasant (chocolate) and aversive (mouldy strawberry) stimuli in 16 healthy volunteers who received a single dose of pramipexole (0.25 mg) and placebo in a double-blind, within-subject, design.

Results

Relative to placebo, pramipexole treatment reduced blood oxygen level-dependent activation to the chocolate stimuli in the areas known to play a key role in reward, including the ventromedial prefrontal cortex, the orbitofrontal cortex, striatum, thalamus and dorsal anterior cingulate cortex. Pramipexole also reduced activation to the aversive condition in the dorsal anterior cingulate cortex. There were no effects of pramipexole on the subjective ratings of the stimuli.

Conclusions

Our results are consistent with an ability of acute, low-dose pramipexole to diminish dopamine-mediated responses to both rewarding and aversive taste stimuli, perhaps through an inhibitory action of D2/3 autoreceptors on phasic burst activity of midbrain dopamine neurones. The ability of pramipexole to inhibit aversive processing might potentiate its adverse behavioural effects and could also play a role in its proposed efficacy in treatment-resistant depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    Article  PubMed  CAS  Google Scholar 

  • Bromberg-Martin ES, Matsumoto M, Hikosaka O (2010) Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68:815–834

    Article  PubMed  CAS  Google Scholar 

  • Campbell-Meiklejohn D, Wakeley J, Herbert V, Cook J, Scollo P, Ray MK, Selvaraj S, Passingham RE, Cowen P, Rogers RD (2011) Serotonin and dopamine play complementary roles in gambling to recover losses. Neuropsychopharmacology 36:402–410

    Article  PubMed  CAS  Google Scholar 

  • Chernoloz O, El Mansari M, Blier P (2009) Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology 34:651–661

    Article  PubMed  CAS  Google Scholar 

  • Collins DL, Neelin P, Peters TM, Evans AC (1994) Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:192–205

    Article  PubMed  CAS  Google Scholar 

  • de Araujo IE, Kringelbach ML, Rolls ET, Hobden P (2003a) Representation of umami taste in the human brain. J Neurophysiol 90:313–319

    Article  PubMed  Google Scholar 

  • de Araujo IE, Kringelbach ML, Rolls ET, McGlone F (2003b) Human cortical responses to water in the mouth, and the effects of thirst. J Neurophysiol 90:1865–1876

    Article  PubMed  Google Scholar 

  • Dooley M, Markham A (1998) Pramipexole. A review of its use in the management of early and advanced Parkinson's disease. Drugs Aging 12:495–514

    Article  PubMed  CAS  Google Scholar 

  • Dziedzicka-Wasylewska M, Ferrari F, Johnson RD, Mierau J, Rogoz Z, Skuza G, Sokoloff P (2001) Mechanisms of action of pramipexole: effects on receptors. Reviews in Contemporary Pharmacotherapy 12:1–31

    CAS  Google Scholar 

  • First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured clinical interview for DSM-IV axis I disorders: clinical version. American Psychiatric Press, Washington

    Google Scholar 

  • Friston KJ, Glaser DE, Henson RN, Kiebel S, Phillips C, Ashburner J (2002) Classical and Bayesian inference in neuroimaging: applications. Neuroimage 16:484–512

    Article  PubMed  CAS  Google Scholar 

  • Harmer CJ, Goodwin GM, Cowen PJ (2009) Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 195:102–108

    Article  PubMed  Google Scholar 

  • Kallweit U, Khatami R, Pizza F, Mathis J, Bassetti CL (2010) Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness. Clin Neuropharmacol 33:276–278

    Article  PubMed  CAS  Google Scholar 

  • Matsumoto M, Hikosaka O (2009) Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 459:837–841

    Article  PubMed  CAS  Google Scholar 

  • McCabe C, Rolls ET (2007) Umami: a delicious flavor formed by convergence of taste and olfactory pathways in the human brain. Eur J Neurosci 25:1855–1864

    Article  PubMed  Google Scholar 

  • McCabe C, Cowen PJ, Harmer CJ (2009) Neural representation of reward in recovered depressed patients. Psychopharmacology (Berl) 205:667–677

    Article  CAS  Google Scholar 

  • McCabe C, Mishor Z, Cowen PJ, Harmer CJ (2010) Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry 67:439–445

    Article  PubMed  CAS  Google Scholar 

  • McCabe C, Huber A, Harmer CJ, Cowen PJ (2011) The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers. Psychopharmacology (Berl) 217:271–278

    Article  CAS  Google Scholar 

  • McCabe C, Woffindale C, Harmer CJ, Cowen PJ (2012) Neural processing of reward and punishment in young people at increased familial risk of depression. Biol Psychiatry 72(7):588–594

    Article  PubMed  Google Scholar 

  • O'Doherty J, Rolls ET, Francis S, Bowtell R, McGlone F (2001) Representation of pleasant and aversive taste in the human brain. J Neurophysiol 85:1315–1321

    PubMed  Google Scholar 

  • Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113

    Article  PubMed  CAS  Google Scholar 

  • Pizzagalli DA, Evins AE, Schetter EC, Frank MJ, Pajtas PE, Santesso DL, Culhane M (2008) Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology (Berl) 196:221–232

    Article  CAS  Google Scholar 

  • Ray N, Strafella AP (2010) Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging. Clin EEG Neurosci 41:87–93

    Article  PubMed  Google Scholar 

  • Riba J, Kramer UM, Heldmann M, Richter S, Munte TF (2008) Dopamine agonist increases risk taking but blunts reward-related brain activity. PLoS One 3:e2479

    Article  PubMed  Google Scholar 

  • Robbins TW, Everitt BJ (1996) Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6:228–236

    Article  PubMed  CAS  Google Scholar 

  • Rolls ET, Kringelbach ML, de Araujo IE (2003) Different representations of pleasant and unpleasant odours in the human brain. Eur J Neurosci 18:695–703

    Article  PubMed  Google Scholar 

  • Rolls ET, McCabe C (2007) Enhanced affective brain representations of chocolate in cravers vs. non-cravers. Eur J Neurosci 26:1067–1076

    Article  PubMed  Google Scholar 

  • Santesso DL, Evins AE, Frank MJ, Schetter EC, Bogdan R, Pizzagalli DA (2009) Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function. Hum Brain Mapp 30:1963–1976

    Article  PubMed  Google Scholar 

  • Sokoloff P, Diaz J, Le Foll B, Guillin O, Leriche L, Bezard E, Gross C (2006) The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS & Neurological Disorders Drug Targets 5:25–43

    Article  CAS  Google Scholar 

  • van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP (2009) Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology 34:2758–2766

    Article  PubMed  Google Scholar 

  • von Zerssen D, Strian F, Schwarz D (1974) Evaluation of depressive states, especially in longitudinal studies. Modern Problems of Pharmacopsychiatry 7:189–202

    Google Scholar 

  • Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, Dolan RJ, Hallett M (2011) Dopamine agonists and risk: impulse control disorders in Parkinson's disease. Brain 134:1438–1446

    Article  PubMed  Google Scholar 

  • Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595

    Article  PubMed  Google Scholar 

  • Wilson JL, Jenkinson M, de Araujo I, Kringelbach ML, Rolls ET, Jezzard P (2002) Fast, fully automated global and local magnetic field optimization for fMRI of the human brain. Neuroimage 17:967–976

    Article  PubMed  Google Scholar 

  • Wise RA (2012) Dual roles of dopamine in food and drug seeking: the drive-reward paradox. Biol Psychiatry. doi:10.1016/j.biopsych.2012.09.001

  • Zald DH, Hagen MC, Pardo JV (2002) Neural correlates of tasting concentrated quinine and sugar solutions. J Neurophysiol 87:1068–1075

    PubMed  Google Scholar 

Download references

Acknowledgments

This work was funded by the Medical Research Council.

Conflict of interest

Dr. McCabe has acted as a consultant to P1Vital, Givaudan, GWpharma and the British Broadcasting Company (BBC). Professor Harmer is a company director of Oxford Psychologists and has acted as a consultant to Servier, GlaxoSmithKline, Astra Zeneca, Johnson & Johnson, Roche, Lundbeck and P1Vital. Professor Cowen is a member of an advisory board for Lundbeck. James Harwood and Sietske Brouwer report no biomedical financial interests or potential conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ciara McCabe.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 2972 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCabe, C., Harwood, J., Brouwer, S. et al. Effects of pramipexole on the processing of rewarding and aversive taste stimuli. Psychopharmacology 228, 283–290 (2013). https://doi.org/10.1007/s00213-013-3033-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-013-3033-9

Keywords

Navigation